Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Research finding paves way for targeted approaches to treating cancer patients

Research finding paves way for targeted approaches to treating cancer patients

Research may lead to new assay to better diagnose bladder cancer in both dogs and humans

Research may lead to new assay to better diagnose bladder cancer in both dogs and humans

NCCN ORP awards six grants to improve care for patients with renal or hematologic malignancies

NCCN ORP awards six grants to improve care for patients with renal or hematologic malignancies

Provectus’ PV-10 data for intralesional treatment of solid tumors presented at ASCO annual meeting

Provectus’ PV-10 data for intralesional treatment of solid tumors presented at ASCO annual meeting

PsiOxus Therapeutics presents positive study results of anti-cancer vaccine Enadenotucirev at ASCO Annual Meeting

PsiOxus Therapeutics presents positive study results of anti-cancer vaccine Enadenotucirev at ASCO Annual Meeting

UIC conducts clinical trial to evaluate three-drug combination therapy for advanced pancreatic cancer

UIC conducts clinical trial to evaluate three-drug combination therapy for advanced pancreatic cancer

Variations in BRCA2 and CHEK2 genes can increase lung cancer risk, study finds

Variations in BRCA2 and CHEK2 genes can increase lung cancer risk, study finds

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint

Novartis LDE225 Phase II study for advanced basal cell carcinoma meets primary endpoint

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

ArQule to present tivantinib clinical trial data at ASCO 2014

ArQule to present tivantinib clinical trial data at ASCO 2014

Deciphera initiates altiratinib MET/TIE2/VEGFR/TRK kinase inhibitor Phase 1 trial for solid tumors

Deciphera initiates altiratinib MET/TIE2/VEGFR/TRK kinase inhibitor Phase 1 trial for solid tumors

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

Researchers identify mutated gene common to rare form of pancreatic cancer

Researchers identify mutated gene common to rare form of pancreatic cancer

Space Station science: Microgravity on human thyroid carcinoma cells

Space Station science: Microgravity on human thyroid carcinoma cells

Vandetanib delays disease progression in elderly NSCLC patients

Vandetanib delays disease progression in elderly NSCLC patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.